Transplantation of fetal mesencephalic tissue in parkinson's disease

Curt R. Freed, Robert E. Breeze, Stuart A. Schneck, Jeffrey H. Kordower, Thomas B. Freeman, C. Warren Olanow

Research output: Contribution to journalLetterpeer-review

20 Scopus citations


To the Editor: The report by Kordower et al. (April 27 issue)1 describes the remarkable survival of dopamine cells after neural transplantation in a patient with Parkinson's disease. These results provide a clear demonstration that the brains of patients with this disease can support embryonic cells, as predicted by the results of studies in animal models. Those of us who have been involved in human neural transplantation for many years have seen clinical improvement and findings on positron-emission tomography (PET) that are compatible with this outcome.24 The clinical methods chosen by this group reflect an amalgamation of techniques. Kordower.

Original languageEnglish (US)
Pages (from-to)730-731
Number of pages2
JournalNew England Journal of Medicine
Issue number11
StatePublished - Sep 14 1995
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Transplantation of fetal mesencephalic tissue in parkinson's disease'. Together they form a unique fingerprint.

Cite this